Agomab and SpyGlass file for IPOs as investor enthusiasm builds after JPM
在摩根大通医疗保健大会后投资者热情升温，Agomab Therapeutics 与 SpyGlass Pharma 提交 IPO 申请

SpyGlass Pharma and Agomab Therapeutics filed for initial public offerings on Friday evening.
SpyGlass Pharma 和 Agomab Therapeutics 于周五晚间提交了首次公开募股（IPO）申请。